About Orakl OncologyAt Orakl Oncology, we combine patient-derived tumor models, experimental drug screening and computational modelling to improve oncology drug development. Our research brings together functional treatment-response measurements, molecular profiles and clinical information where available, creating opportunities to investigate how experimental responses translate into patient outcomes. Our platforms are designed to help anticipate clinical trial outcomes, evaluate therapies and
Neutral 2–4 sentence summary of what working at this company is like, drawn from public reviews and press coverage. Tone, collaboration style, pace, benefits highlights.
£45,000 – £60,000 (Glassdoor, Levels.fyi, 2025)
